A toolbox for accessing federal laboratory innovations and financing the acquisition of new technologies with corporate equity, this book is also a guide to understanding the expertise of specific government laboratories. Entrepreneurs can rapidly accelerate the growth of their companies and become more competitive by acquiring federal laboratory innovations. This book is an indispensable resource for those who want access to the latest breakthrough technologies, most of which can be traced to universities and federally funded laboratories. These taxpayer-funded idea factories can and should be leveraged by companies for competitive advantage. The authors describe how the private sector can engage these labs as long-term strategic partners, as well as development partners for the ongoing, cost-effective improvement of new technologies. Jargon-free and succinct, this guide also explains how to benefit from knowledge of the current technology-transfer landscape in order to maximize this special private-public partnership. No country can equal the United States in research and development assets. But the federal government is not always as successful as it could be in using its authority to encourage such partnerships. It is therefore up to the private sector—entrepreneurs as well as established companies seeking new growth outlets-exploit the information presented here. Included is a directory of federal laboratories with a synopsis of their expertise and contact information, along with copies of the breakthrough technology-transfer legislation that has made technology transfer possible.

Describes the individual capabilities of each of 1,900 unique resources in the federal laboratory system, and provides the name and phone number of each contact. Includes government laboratories, research centers, testing facilities, and special technology information centers. Also includes a list of all federal laboratory technology transfer offices. Organized into 72 subject areas. Detailed indices.

Clinical laboratory tests play an integral role in helping physicians diagnose and treat patients. New developments in laboratory technology offer the prospect of improvements in diagnosis and care, but will place an increased burden on the payment system. Medicare, the federal program providing coverage of health-care services for the elderly and disabled, is the largest payer of clinical laboratory services. Originally designed in the early 1980s, Medicare's payment policy methodology for outpatient laboratory services has not evolved to take into account technology, market, and regulatory changes, and is now outdated. This report examines the current Medicare payment methodology for outpatient clinical laboratory services in the context of environmental and technological trends, evaluates payment policy alternatives, and makes recommendations to improve the system.

This title was first published in 2000: Due to budget cuts and competitiveness pressures, determining the outcome of technology transfer from government R&D laboratories to private industry and entrepreneurial start-ups is of increasing interest. This book presents a series of case studies of successful technology transfer by examining the same list of topics for each case. It presents a format for analyzing the cases, topic by topic - a methodology that could be used by any R&D laboratory. The book also goes one step further and compares the cases that took place prior to national technology transfer legislation with those cases that took place after passage of such legislation. An additional feature is the summary of existing attempts to measure and evaluate technology transfer. This follows a backgroudn section on the technology policy context. The analysis finds that there is a significant commercial impact from government laboratory transfer using this approach.